COVID-19 gives Akili’s digital ADHD treatment an early debut in US

COVID-19 gives Akili’s digital ADHD treatment an early debut in US

Source: 
Pharmaforum
snippet: 

An app to treat children with attention-deficit hyperactivity disorder (ADHD) developed by Akili has been made available ahead of its FDA approval, under an agency scheme to speed up access to digital therapies during the coronavirus pandemic.